ArticleHypertension (Dallas, Tex. : 1979)2026

Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization.

Yifan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.